COR

Company Overview — What Does Cencora, Inc. Do?

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. Cencora, Inc. (COR) is classified as a large-cap stock in the Consumer Staples sector, specifically within the Wholesale industry. The company is led by CEO Steven H. Collis and employs approximately 42,000 people, headquartered in Chesterbrook, Pennsylvania. With a market capitalization of $61.8B, COR is one of the prominent companies in the Consumer Staples sector.

Cencora, Inc. (COR) Stock Rating — Reduce (April 2026)

As of April 2026, Cencora, Inc. receives a Reduce rating with a composite score of 35.3/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.COR ranks #3,083 out of 4,446 stocks in our coverage universe. Within the Consumer Staples sector, Cencora, Inc. ranks #129 of 180 stocks, placing it in the lower half of its Consumer Staples peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

COR Stock Price and 52-Week Range

Cencora, Inc. (COR) currently trades at $320.82. The stock lost $1.64 (0.5%) in the most recent trading session. The 52-week high for COR is $377.54, which means the stock is currently trading -15.0% from its annual peak. The 52-week low is $264.33, putting the stock 21.4% above its annual trough. Recent trading volume was 1.0M shares, reflecting moderate market activity.

Is COR Overvalued or Undervalued? — Valuation Analysis

Cencora, Inc. (COR) carries a value factor score of 43/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 25.30x, compared to the Consumer Staples sector average of 33.11x — a discount of 24%. The price-to-book ratio stands at 29.78x, versus the sector average of 1.74x. The price-to-sales ratio is 0.19x, compared to 0.35x for the average Consumer Staples stock. On an enterprise value basis, COR trades at 20.87x EV/EBITDA, versus 6.93x for the sector.

Overall, COR's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.

Cencora, Inc. Profitability — ROE, Margins, and Quality Score

Cencora, Inc. (COR) earns a quality factor score of 10/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is 117.7%, compared to the Consumer Staples sector average of 7.7%, which demonstrates strong shareholder value creation. Return on assets (ROA) comes in at 3.1% versus the sector average of 3.1%.

On a margin basis, Cencora, Inc. reports gross margins of 3.6%, compared to 26.2% for the sector. The operating margin is 1.1% (sector: 2.9%). Net profit margin stands at 0.8%, versus 1.6% for the average Consumer Staples stock. Revenue growth is running at 15.8% on a trailing basis, compared to 3.1% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

COR Debt, Balance Sheet, and Financial Health

Cencora, Inc. has a debt-to-equity ratio of 378.0%, compared to the Consumer Staples sector average of 72.0%. This elevated leverage warrants close monitoring, as it increases the company's sensitivity to rising interest rates and economic downturns. The current ratio is 0.92x, which may signal near-term liquidity tightness. Total debt on the balance sheet is $7.92B.

COR has a beta of 0.19, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for Cencora, Inc. is 90/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.

Cencora, Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, Cencora, Inc. reported revenue of $323.54B and earnings per share (EPS) of $2.88. Net income for the quarter was $2.47B. Gross margin was 3.6%. Operating income came in at $3.37B.

In Q1 2026, Cencora, Inc. reported revenue of $85.93B and earnings per share (EPS) of $2.88. Net income for the quarter was $566M. Gross margin was 3.6%. Revenue grew 5.5% year-over-year compared to Q1 2025. Operating income came in at $760M.

In FY 2025, Cencora, Inc. reported revenue of $321.33B and earnings per share (EPS) of $8.02. Net income for the quarter was $1.57B. Gross margin was 3.6%. Revenue grew 9.3% year-over-year compared to FY 2024. Operating income came in at $2.63B.

In Q3 2025, Cencora, Inc. reported revenue of $80.66B and earnings per share (EPS) of $3.55. Net income for the quarter was $690M. Gross margin was 3.6%. Revenue grew 8.7% year-over-year compared to Q3 2024. Operating income came in at $868M.

Over the past 8 quarters, Cencora, Inc. has demonstrated a growth trajectory, with revenue expanding from $74.24B to $323.54B. Investors analyzing COR stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

COR Dividend Yield and Income Analysis

Cencora, Inc. (COR) currently pays a dividend yield of 0.7%. At this yield, a $10,000 investment in COR stock would generate approximately $$72.00 in annual dividend income. This compares to the Consumer Staples sector average dividend yield of 0.4%, meaning COR offers above-average income for its sector.

COR Momentum and Technical Analysis Profile

Cencora, Inc. (COR) has a momentum factor score of 52/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 27/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 11/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.

COR vs Competitors — Consumer Staples Sector Ranking and Peer Comparison

Within the Consumer Staples sector, Cencora, Inc. (COR) ranks #129 out of 180 stocks based on the Blank Capital composite score. This places COR in the lower half of all Consumer Staples stocks in our coverage universe. Key competitors and sector peers include Ituran Location & Control Ltd. (ITRN) with a score of 60.3/100, DARLING INGREDIENTS INC. (DAR) with a score of 52.9/100, Bunge Global SA (BG) with a score of 53.0/100, SANFILIPPO JOHN B & SON INC (JBSS) with a score of 54.1/100, and Archer-Daniels-Midland Co (ADM) with a score of 52.2/100.

Comparing COR against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full COR vs S&P 500 (SPY) comparison to assess how Cencora, Inc. stacks up against the broader market across all factor dimensions.

COR Next Earnings Date

No upcoming earnings date has been announced for Cencora, Inc. (COR) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy COR? — Investment Thesis Summary

The quantitative profile for Cencora, Inc. suggests caution. The quality score of 10/100 flags below-average profitability. Low volatility (stability score 90/100) reduces downside risk.

In summary, Cencora, Inc. (COR) earns a Reduce rating with a composite score of 35.3/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on COR stock.

Related Resources for COR Investors

Explore more research and tools: COR vs S&P 500 comparison, top Consumer Staples stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare COR head-to-head with peers: COR vs ITRN, COR vs DAR, COR vs BG.